文献速递认知障碍与痴呆

小胶质细胞P2Y12通过Ca2+活动介导的神经炎症和血管损伤驱动慢性脑低灌注

Microglial P2Y12 Drives Chronic Cerebral Hypoperfusion via Ca2+ Activity–Mediated Neuroinflammation and Vascular Injury
RSS 订阅 · Stroke

该研究在小鼠慢性脑低灌注模型中证实,小胶质细胞P2Y12通过介导Ca2+活动驱动神经炎症和血管损伤,遗传敲除P2Y12或使用尼莫地平可改善认知、灌注和血管完整性。

要点

  • 慢性脑低灌注诱导海马小胶质细胞P2Y12持续上调,遗传敲除可改善认知和灌注。
  • P2Y12信号介导血管周围小胶质细胞异常Ca2+活动,敲除可消除该病理表型。
  • 尼莫地平可重现遗传敲除的保护效应,改善模型小鼠认知和血管功能。

核心结论

  • 小胶质细胞P2Y12/Ca2+轴是慢性脑低灌注诱导血管性认知障碍的关键致病驱动因素,将小胶质细胞持续激活与神经炎症和脑微血管损伤联系起来。
  • 尼莫地平药理抑制该轴可重现遗传性P2Y12缺失的获益,为血管性认知障碍治疗提供了一种临床可转化的治疗策略。
  • 所有结论均由本研究获得的行为学、影像学和分子实验结果充分支持。

研究设计与样本

  • 研究为假设检验型动物实验,采用成年雄性小鼠通过不对称双侧颈动脉狭窄诱导血管性认知障碍。
  • 使用P2Y12flox/flox:CX3CR1CreER小鼠生成小胶质细胞特异性P2Y12敲除小鼠。
  • 认知功能通过物体位置识别、三箱社交互动和Morris水迷宫测试评估。
  • 脑血流通过激光散斑对比成像和功能性超声测量。
  • 神经炎症、微血管完整性和血管周围小胶质细胞Ca2+活动通过免疫荧光、流式细胞术和双光子GCaMP6f成像评估。

主要发现

  • 所有实验动物在整个过程中表现出一致的基线生理和行为状态,组间无差异。
  • 慢性脑低灌注诱导海马小胶质细胞P2Y12持续上调。
  • 小胶质细胞P2Y12遗传消融有效改善低灌注触发的认知障碍、海马萎缩和神经元丢失,维持脑灌注,并抑制持续的小胶质细胞炎症激活和病理性的小胶质细胞-微血管相互作用。
  • 机制上,P2Y12信号介导血管周围小胶质细胞中异常ATP触发的Ca2+过度活跃,该病理表型被小胶质细胞P2Y12缺失消除。
  • 尼莫地平药理干预重现遗传性P2Y12抑制的保护效应,使异常小胶质细胞钙活动正常化,减轻神经炎症和破坏性小胶质细胞-血管交互,维持脑结构和灌注稳态,并挽救模型小鼠的认知功能障碍,同时对对照动物无不良影响。

临床怎么用

  • 作者认为,尼莫地平药理抑制小胶质细胞P2Y12/Ca2+轴可重现遗传性P2Y12缺失的获益,为血管性认知障碍治疗提供了一种临床可转化的治疗策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「局限性」,故未列出该栏;全文请点「阅读原文」。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Volume 57, Issue 11, Page 3385-3401, November 1, 2026. BACKGROUND:Chronic cerebral hypoperfusion is a major driver of vascular cognitive impairment (VCI), but the role of microglial purinergic signaling in chronic cerebral hypoperfusion–induced neurovascular dysfunction remains undefined. This hypothesis-testing study with a novel research premise aimed to address this knowledge gap by clarifying whether microglial P2Y12 (purinergic receptor P2Y12), a microglia-enriched G-protein–coupled receptor, mediates VCI pathogenesis through regulation of microglial calcium signaling and microglia-vascular crosstalk under chronic cerebral hypoperfusion conditions.METHODS:VCI was induced in adult male mice by asymmetrical bilateral carotid artery stenosis. Microglia-specific P2Y12 knockout mice were generated using P2Y12flox/flox:CX3CR1 (CX3C chemokine receptor 1)CreERmice. Cognitive function was assessed by object location recognition, 3-chamber social interaction, and Morris water maze tests. Cerebral blood flow was measured by laser speckle contrast imaging and functional ultrasound. Neuroinflammation, microvascular integrity, and perivascular microglial Ca2+activity were evaluated by immunofluorescence, flow cytometry, and 2-photon GCaMP6f (the fast variant of the genetically encoded calcium indicator GCaMP6) imaging. The clinically approved L-type Ca2+channel blocker nimodipine was administered starting 42 days postasymmetrical bilateral carotid artery stenosis.RESULTS:All experimental animals exhibited consistent baseline physiological and behavioral status without intergroup differences throughout the procedure. Chronic cerebral hypoperfusion induced persistent upregulation of P2Y12 in hippocampal microglia. Microglial P2Y12 genetic ablation effectively ameliorated hypoperfusion-triggered cognitive impairment, hippocampal atrophy, and neuronal loss, preserved cerebral perfusion, and inhibited sustained microglial inflammatory activation and pathological microglia-microvessel interaction. Mechanistically, P2Y12 signaling mediated aberrant ATP-triggered Ca2+hyperactivity in perivascular microglia, and this pathological phenotype was eliminated by microglial P2Y12 deletion. Pharmacological intervention with nimodipine recapitulated the protective effects of genetic P2Y12 inhibition, normalizing abnormal microglial calcium activity, alleviating neuroinflammation and disruptive microglia-vascular crosstalk, maintaining cerebral structural and perfusion homeostasis, and rescuing cognitive dysfunction in model mice, while exerting no adverse effects on control animals. Conclusions The microglial P2Y12/Ca2+ axis is a critical pathogenic driver of chronic cerebral hypoperfusion-induced VCI, linking sustained microglial activation to neuroinflammation and cerebral microvascular injury. Pharmacological inhibition of this axis with nimodipine recapitulates the benefits of genetic P2Y12 deletion, identifying a clinically translatable therapeutic strategy for VCI treatment. All conclusions are fully supported by the comprehensive behavioral, imaging, and molecular experimental results obtained in this study.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Microglial P2Y12 Drives Chronic Cerebral Hypoperfusion via Ca2+ Activity–Mediated Neuroinflammation and Vascular Injury

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。